• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 的发病机制与临床表现。

COVID-19 Pathogenesis and Clinical Manifestations.

机构信息

Department of Internal Medicine, John H. Stroger Jr. Hospital of Cook County, Chicago, IL, USA.

Division of Infectious Diseases, University of Mississippi Medical Center, Jackson, MS, USA.

出版信息

Infect Dis Clin North Am. 2022 Jun;36(2):231-249. doi: 10.1016/j.idc.2022.01.003. Epub 2022 Feb 1.

DOI:10.1016/j.idc.2022.01.003
PMID:35636898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8806149/
Abstract

In this review, we summarize the current knowledge about the virology, the host-pathogen interactions and pathogenesis of coronavirus disease 2019 in humans. We also describe the various clinical presentations of the disease including respiratory system and extrapulmonary manifestations.

摘要

在这篇综述中，我们总结了目前关于人类 2019 年冠状病毒病的病毒学、宿主-病原体相互作用和发病机制的知识。我们还描述了该病的各种临床表现，包括呼吸系统和肺外表现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/a3c661576067/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/ade906b184f5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/1a3b12df7c7f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/b3d63bb754f4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/a3c661576067/gr4_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/ade906b184f5/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/1a3b12df7c7f/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/b3d63bb754f4/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a4fc/8806149/a3c661576067/gr4_lrg.jpg

相似文献

1
COVID-19 Pathogenesis and Clinical Manifestations.COVID-19 的发病机制与临床表现。
Infect Dis Clin North Am. 2022 Jun;36(2):231-249. doi: 10.1016/j.idc.2022.01.003. Epub 2022 Feb 1.
2
Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases.新型冠状病毒病与其他冠状病毒病的异同。
Annu Rev Microbiol. 2021 Oct 8;75:19-47. doi: 10.1146/annurev-micro-110520-023212. Epub 2021 Jan 25.
3
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.严重急性呼吸综合征冠状病毒 2 与宿主抗病毒防御之间的拔河比赛：来自其他致病病毒的经验教训。
Emerg Microbes Infect. 2020 Mar 14;9(1):558-570. doi: 10.1080/22221751.2020.1736644. eCollection 2020.
4
Atypical Manifestations of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children: A Systematic Review.儿童严重急性呼吸综合征冠状病毒2感染的非典型表现：一项系统综述
Curr Pediatr Rev. 2021;17(3):162-171. doi: 10.2174/1573396317666210406153302.
5
An overview of potential therapeutic agents to treat COVID-19.治疗 COVID-19 的潜在治疗药物概述。
Biosci Trends. 2020 Nov 4;14(5):318-327. doi: 10.5582/bst.2020.03345. Epub 2020 Oct 25.
6
COVID-19: a conundrum to decipher.COVID-19：一个待破译的谜。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5830-5841. doi: 10.26355/eurrev_202005_21378.
7
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.SARS-CoV-2：致病机制与宿主免疫应答。
Adv Exp Med Biol. 2021;1313:99-134. doi: 10.1007/978-3-030-67452-6_6.
8
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
9
Cardiovascular Tropism and Sequelae of SARS-CoV-2 Infection.心血管亲嗜性与 SARS-CoV-2 感染的后遗症。
Viruses. 2022 May 25;14(6):1137. doi: 10.3390/v14061137.
10
Extra-respiratory manifestations of COVID-19.COVID-19 的呼吸外表现。
Int J Antimicrob Agents. 2020 Aug;56(2):106024. doi: 10.1016/j.ijantimicag.2020.106024. Epub 2020 May 22.

引用本文的文献

1
IL-4 and TGF-β regulate inflammatory cytokines and cellular infiltration in the lung and systemic IL-6 in mouse-adapted SARS-CoV-2 infection.白细胞介素-4和转化生长因子-β在适应小鼠的严重急性呼吸综合征冠状病毒2感染中调节肺部的炎性细胞因子和细胞浸润以及全身白细胞介素-6。
Immunohorizons. 2025 Aug 25;9(9). doi: 10.1093/immhor/vlaf032.
2
SOCS Proteins: Key Players in Immune Regulation During SARS-CoV-2 Infection.SOCS蛋白：新冠病毒感染期间免疫调节的关键参与者
Eur J Immunol. 2025 Aug;55(8):e51645. doi: 10.1002/eji.202451645.
3
Pulmonary function and comparative SARS-CoV-2 RBD-specific IgG antibody response among the COVID-19 recovered group.

本文引用的文献

1
Risks of myocarditis, pericarditis, and cardiac arrhythmias associated with COVID-19 vaccination or SARS-CoV-2 infection.与 COVID-19 疫苗接种或 SARS-CoV-2 感染相关的心肌炎、心包炎和心律失常风险。
Nat Med. 2022 Feb;28(2):410-422. doi: 10.1038/s41591-021-01630-0. Epub 2021 Dec 14.
2
Addressing and Inspiring Vaccine Confidence in Black, Indigenous, and People of Color During the Coronavirus Disease 2019 Pandemic.在2019年冠状病毒病大流行期间增强和激发黑人和原住民以及有色人种对疫苗的信心
Open Forum Infect Dis. 2021 Aug 9;8(9):ofab417. doi: 10.1093/ofid/ofab417. eCollection 2021 Sep.
3
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China.
新冠康复组的肺功能及SARS-CoV-2受体结合域特异性IgG抗体反应比较
PLoS One. 2025 Jul 11;20(7):e0318959. doi: 10.1371/journal.pone.0318959. eCollection 2025.
4
IL-4 and TGF-β Regulate Inflammatory cytokines and Cellular Infiltration in the Lung in Mouse-adapted SARS-CoV-2 Infection.白细胞介素-4和转化生长因子-β调节适应小鼠的严重急性呼吸综合征冠状病毒2感染中肺部的炎性细胞因子和细胞浸润。
bioRxiv. 2025 May 14:2025.05.13.653138. doi: 10.1101/2025.05.13.653138.
5
Evaluation of physiological severity scores for predicting COVID-19 disease progression: a retrospective study.评估用于预测COVID-19疾病进展的生理严重程度评分：一项回顾性研究。
BMC Infect Dis. 2025 May 26;25(1):758. doi: 10.1186/s12879-025-11127-7.
6
Nanomaterial-Based Biosensors for the Detection of COVID-19.用于检测新型冠状病毒肺炎的纳米材料基生物传感器
Indian J Microbiol. 2025 Mar;65(1):120-136. doi: 10.1007/s12088-024-01336-0. Epub 2024 Jun 23.
7
Antivirals in COVID-19: A Focus on Pediatric Cardiac Patients.新冠疫情中的抗病毒药物：聚焦儿科心脏病患者
Can J Infect Dis Med Microbiol. 2025 Mar 30;2025:4573096. doi: 10.1155/cjid/4573096. eCollection 2025.
8
Clinical Features of SARS-CoV-2 Infected Patients in a Large Population Cohort from the South-West Region of Romania.罗马尼亚西南部地区一大群队列中感染新型冠状病毒2的患者的临床特征
Curr Health Sci J. 2024 Oct-Dec;50(4):498-507. doi: 10.12865/CHSJ.50.04.04. Epub 2024 Dec 31.
9
Pulmonary Function Test: A Mainstay for Evaluating Respiratory Health in Patients Recovered from COVID-19 Infection.肺功能测试：评估新冠病毒感染康复患者呼吸健康的主要手段。
J Pharm Bioallied Sci. 2024 Dec;16(Suppl 4):S3318-S3321. doi: 10.4103/jpbs.jpbs_780_24. Epub 2024 Sep 20.
10
Assessing the mask-wearing habit as a contributing factor for COVID-19-associated mucormycosis.评估佩戴口罩习惯作为新冠相关毛霉菌病的一个促成因素。
J Family Med Prim Care. 2024 Dec;13(12):5766-5774. doi: 10.4103/jfmpc.jfmpc_887_24. Epub 2024 Dec 9.
中国广州新型严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）德尔塔变异株（VOC）的传播、病毒动力学及临床特征
EClinicalMedicine. 2021 Oct;40:101129. doi: 10.1016/j.eclinm.2021.101129. Epub 2021 Sep 12.
4
Post-Acute Sequelae of SARS-CoV-2 Infection Among Adults Aged ≥18 Years - Long Beach, California, April 1-December 10, 2020.成人 SARS-CoV-2 感染的急性后期效应 - 加利福尼亚州长滩，2020 年 4 月 1 日至 12 月 10 日。
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1274-1277. doi: 10.15585/mmwr.mm7037a2.
5
Association Between COVID-19 and Myocarditis Using Hospital-Based Administrative Data - United States, March 2020-January 2021.基于医院管理数据的 2020 年 3 月-2021 年 1 月期间美国 COVID-19 与心肌炎之间的关联
MMWR Morb Mortal Wkly Rep. 2021 Sep 3;70(35):1228-1232. doi: 10.15585/mmwr.mm7035e5.
6
SARS-CoV-2 variants, spike mutations and immune escape.SARS-CoV-2 变体、刺突突变和免疫逃逸。
Nat Rev Microbiol. 2021 Jul;19(7):409-424. doi: 10.1038/s41579-021-00573-0. Epub 2021 Jun 1.
7
Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments.长新冠或新冠后综合征：推测的病理生理学、危险因素和治疗方法。
Infect Dis (Lond). 2021 Oct;53(10):737-754. doi: 10.1080/23744235.2021.1924397. Epub 2021 May 22.
8
On the origin and evolution of SARS-CoV-2.关于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的起源与进化
Exp Mol Med. 2021 Apr;53(4):537-547. doi: 10.1038/s12276-021-00604-z. Epub 2021 Apr 16.
9
Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a whole-genome sequencing and hospital-based cohort study.英国伦敦出现的 SARS-CoV-2 B.1.1.7 谱系的基因组特征和临床效果：全基因组测序和基于医院的队列研究。
Lancet Infect Dis. 2021 Sep;21(9):1246-1256. doi: 10.1016/S1473-3099(21)00170-5. Epub 2021 Apr 12.
10
Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.组织蛋白酶L在SARS-CoV-2感染人类和人源化小鼠过程中起关键作用，是新药研发的一个有前景的靶点。
Signal Transduct Target Ther. 2021 Mar 27;6(1):134. doi: 10.1038/s41392-021-00558-8.